Random non-fasting C-peptide testing can identify patients with insulin-treated type 2 diabetes at high risk of hypoglycaemia
Diabetologia - Clinical and Experimental Diabetes and Metabolism | Dec 09, 2017
Diabetologia - Clinical and Experimental Diabetes and Metabolism | Dec 09, 2017